add_filter( 'unzip_file_use_ziparchive', '__return_false' );

Attachment II – General information for treatment


Emergencies (including suspected emergencies) such as heart attack, anaphylactic shock, diabetic coma, hypoglycaemic shock, apoplexia, etc. are the preserve of emergency medicine and should not be treated primarily with BICOM bioresonance therapy.



The device is intended for use in medical and naturopathic practices to cure, alleviate or prevent diseases and should only be used by approved therapists or by trained assistants under their supervision. It is not intended to be used by amateurs.

1. General basic rules

  • Do not use too many programs at once in one session. Depending on the patient’s responsiveness and resilience, perform 3, up to a maximum of 6, therapies.
  • Select therapy programs in line with the empirical values contained in our literature and referred to at our seminars or following testing and/or diagnosis.
  • Give the patient plenty of still high-resistance water to drink following therapy.
  • Do not place electrodes on open wounds.
  • The modulation mat does not need to be placed on the skin. It can be placed on clothing. It is designed like this for practical reasons.
  • Consequently the material has not undergone a cutaneous tolerance test. The material used is biocompatible.
  • Do not allow the patients to drink any alcohol the day they receive therapy.
  • Activate eliminating organs if necessary.
  • It is recommended that chronically sick patients should not be treated at intervals of less than 5 to 7 days.
  • Patients with acute illnesses can also be treated daily.
  • Ensure the room is adequately ventilated.
  • Always keep the operating instructions at hand to refer to.
  • Do not allow untrained staff or those who are unfamiliar with the device to perform treatment. It makes sense, and is even important, to ask the patient to report any reactions which occur during therapy. These may be sensations of warmth or cold, tingling, palpitations, pain, outbreaks of sweating or sensations of pressure.
  • If possible, continue therapy with the same setting or the same program until all the reactions which occurred during therapy have subsided. There may be exceptional situations where the person treating the patient must then themselves assess the risk of continuing treatment such as with asthmatics, neurodermatitis sufferers, epileptics, children with convulsions, etc.

2. Help with initial aggravation and hypersensitive reactions

  • Apply H therapy (no. 127) with the lowest amplification/ attenuation or
  • H+Di (no. 128) with the lowest amplification/attenuation.
  • Give the patient plenty of still water to drink to eliminate toxins.
  • Search for possible therapy blocks.
  • Check the patient’s responsiveness and immune defence system.
  • If necessary, prescribe medication to support hepatic, renal or bladder function and lymph discharge.
  • If unpleasant sensations such as dizziness or nausea or congestion in the head occur during therapy or at the end of therapy, interrupt therapy briefly and treat the patient with program 127 or 128 until they feel better again. The original electrode positioning should be kept. Therapy is then continued until the therapy stage is completed.
  • It should be noted here that slight initial exacerbation is thoroughly desirable. Initial aggravation can generally be reduced by drinking plenty of low-mineral water.

3. Particular considerations for pregnant women

  • Do not treat in the first three months of pregnancy for forensic reasons.
  • Do not specifically eliminate toxins, medication, etc. throughout the entire pregnancy.
  • Do not place magnetic depth probes or magnetic articulated probes on the abdomen.

4. Particular considerations for patients who are allergic to insect bites or have an emergency set

  • Keep the emergency instruments handy after treatment just in case.
  • This applies with all other indications where these instruments were needed in the
5. Patients with heart pacemakers
  • For forensic reasons do not place magnetic electrodes, and especially magnetic articulated or magnetic depth probes, on or near the pacemaker.
  • Do not place input and output electrodes on the implant.

6. Important considerations with neurodermatitis and asthma

  • The special recommendations in our literature and given at our seminars should be observed with these particular symptoms.
  • Perform supporting measures beforehand and build up patient physically.
  • Remove blocks and eliminate harmful substances carefully.
  • If necessary, prescribe abstinence from certain substances and perform mycosis therapy.
  • Use allopathic remedies where this is absolutely necessary.
  • Finally treat neurodermatitis.
  • With asthmatic patients, keep the emergency instruments handy just in case.

7. Particular considerations with autoimmune disorders (MS, rheumatism, etc.)

  • Never treat the immune system at the beginning.
  • Determine and treat viral infections and mycosis or parasite infestation.
  • Check organ function and begin with supporting measures.
  • Build the patient up physically.
  • Follow particular recommendations in our literature.
  • Test therapy time and amplification.

8. Important considerations with metal implants and if metal fragments are present

  • Do not directly treat the site of the implant or of the fragment with the magnetic depth probe or articulated probe.

9. Vital medication

  • Do not abruptly discontinue permanent medication or vital medication but test whether they are tolerated.

10. Caution with permanent medication

  • Where patients are on long-term or permanent medication, they can be expected to be blocked or their immune system severely impaired. It is therefore recommended simply to perform basic therapy at the start of BICOM therapy to allow the patient’s response to be observed.

11. Anaesthetics and psycho pharmaceuticals and similar medication

  • When eliminating anaesthetics, psycho pharmaceuticals and substances with a similar effect, alert the patient to the fact that road safety may possibly be limited due to a temporary reduction in responsiveness.

12. Hyperergic patients and those liable to anaphylactic shock

  • Do not start straight away by treating the allergen or toxin.
  • Ensure the emergency instruments are kept at hand.
  • Build up and stabilise organ function.
  • Take extreme care with the provocation test – only following clinical safeguards.

13. Contra-indications with BICOM cupping electrode therapy

BICOM cupping electrode therapy should not be used on patients

  • with a high temperature
  • with advanced diabetes
  • with anaemia and leukaemia
  • with impaired blood clotting
  • with severe heart problems
  • with extreme tiredness and cachexia
  • during pregnancy
  • Take care also with bleeding cupping in patients with anti-coagulants.

Hygiene procedures, as mentioned and as required for dealing with active tissue, should be observed.

14. Contra-indications with the magnetic field therapy (DMI – Dynamic Multi Impulse Packs)

The DMI function should not be used on patients following organ transplantation, haemorrhaging or with haemophiliacs and patients with a tendency to haemorrhage.

15. Contra-indications with organ transplants

Attention with organ transplants: patients must take immunosuppressants due to the risk of rejection. Using Bicom could be contra indicative. Treatment must therefore be considered carefully. Take particular care with immuno-stimulating programs. If uncertain, do not treat with bioresonance.

16. Physical reactions in the therapist

If bioresonance therapy makes therapists tired, they may have a tissue block in their body which should be resolved. You are therefore recommended to fortify yourself physically from time to time. In doing so, you will do yourself a favour as well.

17. Training

The visit of an introductory seminar is obligatory. We do recommend furthering your knowledge by attending an advanced seminar. Please ask your country representative for the dates.


This entry was posted in Uncategorised. Bookmark the permalink.